Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Enhabit, Inc. (EHAB : NYSE)
 
 • Company Description   
Enhabit Inc. provides home health and hospice services. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration and skilled observation and assessment services; practices to treat chronic diseases and conditions. Enhabit Inc., formerly known as EHABIT INC, is based in Dallas, Texas.

Number of Employees: 10,700

 
 • Price / Volume Information   
Yesterday's Closing Price: $7.05 Daily Weekly Monthly
20 Day Moving Average: 760,060 shares
Shares Outstanding: 50.64 (millions)
Market Capitalization: $356.99 (millions)
Beta: 1.72
52 Week High: $10.91
52 Week Low: $6.85
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -27.91% -31.17%
12 Week -8.20% -22.53%
Year To Date -9.73% -15.18%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
6688 N. CENTRAL EXPRESSWAY SUITE 1300
-
DALLAS,TX 75206
USA		 ph: 214-239-6500
fax: -		 investorrelations@ehab.com http://www.ehab.com
 
 • General Corporate Information   
Officers
Barb Jacobsmeyer - President and Chief Executive Officer and Director
Jeffrey W. Bolton - Chairman and Director
Ryan Solomon - Chief Financial Officer
Collin McQuiddy - Chief Accounting Officer
Tina L. Brown-Stevenson - Director

Peer Information
Enhabit, Inc. (CHCR)
Enhabit, Inc. (ESRX)
Enhabit, Inc. (MYDP)
Enhabit, Inc. (COR)
Enhabit, Inc. (GBCS)
Enhabit, Inc. (LAXAF)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 29332G102
SIC: 8082
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/05/25
Share - Related Items
Shares Outstanding: 50.64
Most Recent Split Date: (:1)
Beta: 1.72
Market Capitalization: $356.99 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.11 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $0.44 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/05/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 16.15
Trailing 12 Months: 29.38
PEG Ratio: -
Price Ratios
Price/Book: 0.63
Price/Cash Flow: 1.73
Price / Sales: 0.35
EPS Growth
vs. Year Ago Period: 42.86%
vs. Previous Quarter: 150.00%
Sales Growth
vs. Year Ago Period: -0.95%
vs. Previous Quarter: 0.66%
ROE
06/30/25 - -
03/31/25 - 2.02
12/31/24 - 1.66
ROA
06/30/25 - -
03/31/25 - 0.94
12/31/24 - 0.78
Current Ratio
06/30/25 - -
03/31/25 - 1.49
12/31/24 - 1.53
Quick Ratio
06/30/25 - -
03/31/25 - 1.49
12/31/24 - 1.53
Operating Margin
06/30/25 - -
03/31/25 - 1.18
12/31/24 - 1.02
Net Margin
06/30/25 - -
03/31/25 - -13.43
12/31/24 - -15.10
Pre-Tax Margin
06/30/25 - -
03/31/25 - -12.98
12/31/24 - -15.27
Book Value
06/30/25 - -
03/31/25 - 11.22
12/31/24 - 10.92
Inventory Turnover
06/30/25 - -
03/31/25 - -
12/31/24 - -
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.82
12/31/24 - 0.90
Debt-to-Capital
06/30/25 - -
03/31/25 - 45.12
12/31/24 - 47.30
 

Powered by Zacks Investment Research ©